Cite
HARVARD Citation
Koskinas, K. et al. (n.d.). Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: insights from the PACMAN-AMI randomized trial. European heart journal. p. . [Online].